Diapositive 1

1576 / 1851

• Use of concomitant chemotherapy
– No = 19%
– Yes = 81%
• Regimens
– Cisplatin 55%
– Cis + 5FU 31%
– 5FU + MMC 5%
– Other 9%
Gaffney DK, et al. Int J Gynecol Cancer. 2009;19:163-7